Tag: SPI-1005
Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials ... Read More
Sound Pharmaceuticals bags FDA fast track status for SPI-1005 in Meniere’s Disease
US biopharma company Sound Pharmaceuticals said that its investigational drug SPI-1005 has secured the fast track designation (FTD) from the US Food and Drug Administration ... Read More